Skip to content
10-Q

Quarterly Report

BioCrude Technologies USA, Inc.

0001731122-24-001220

← back to feed
Filed
Aug 9, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 9, 2024 50.85M sh
Capex Q2 2024 · Jun 30, 2024 $1.24K
Capex Q2 2024 · Jun 30, 2023 $0
Short Term Debt Q2 2024 · Jun 30, 2024 $132.85K
Short Term Debt Q2 2024 · Dec 31, 2023 $133.97K
Stockholders Equity Q2 2024 · Jun 30, 2024 −$222.51K
Stockholders Equity Q2 2024 · Dec 31, 2023 −$234.08K
Current Liabilities Q2 2024 · Jun 30, 2024 $276.88K
Current Liabilities Q2 2024 · Dec 31, 2023 $253.99K
Total Liabilities Q2 2024 · Jun 30, 2024 $276.88K
Total Liabilities Q2 2024 · Dec 31, 2023 $253.99K
Current Assets Q2 2024 · Jun 30, 2024 $35.45K
Current Assets Q2 2024 · Dec 31, 2023 $0
Total Assets Q2 2024 · Jun 30, 2024 $50.39K
Total Assets Q2 2024 · Dec 31, 2023 $15.93K
Revenue Q2 2024 · Jun 30, 2024 $0
Revenue Q2 2024 · Jun 30, 2024 $0
Revenue Q2 2024 · Jun 30, 2023 $0
Revenue Q2 2024 · Jun 30, 2023 $0
Shares Diluted Q2 2024 · Jun 30, 2023 50.76M sh
Shares Diluted Q2 2024 · Jun 30, 2023 50.76M sh
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$75.3K
Eps Diluted Q2 2024 · Jun 30, 2023 $0.00
Eps Diluted Q2 2024 · Jun 30, 2023 $0.00
Eps Basic Q2 2024 · Jun 30, 2023 $0.00
Eps Basic Q2 2024 · Jun 30, 2023 $0.00
Sga Expense Q2 2024 · Jun 30, 2023 $93.76K
Sga Expense Q2 2024 · Jun 30, 2023 $155.22K
Net Income Q2 2024 · Jun 30, 2023 −$94.71K
Net Income Q2 2024 · Mar 31, 2023 −$62.39K
Operating Income Q2 2024 · Jun 30, 2023 −$93.76K
Operating Income Q2 2024 · Jun 30, 2023 −$155.22K